Neuphoria Therapeutics Inc. - Common Stock (NEUP) Stock Price, News & Analysis

Company Overview

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Key Stats

• Today's Range: $3.07 to $3.30
• 50-Day Range: N/A
• 52-Week Range: $2.12 to $16.08
• Volume: 18,246 shs
• Average Volume: 60,681 shs
• Market Capitalization: $5.21 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NEUP Stock Analysis - Frequently Asked Questions

How have NEUP shares performed this year?

Neuphoria Therapeutics Inc. - Common Stock's stock was trading at $3.20 at the beginning of 2025. Since then, NEUP stock has increased by 0.0% and is now trading at $3.20.
View the best growth stocks for 2025 here.

How do I buy shares of Neuphoria Therapeutics Inc. - Common Stock?

Shares of NEUP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:NEUP
• CUSIP: N/A
• CIK: 1191070
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,629,000
• Free Float: N/A
• Market Cap: $5.21 million
• Optionable: N/A
• Beta: 0.26